<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en" dir="ltr">
  <head>
    <meta http-equiv="Content-Type" content="text/html; charset=UTF-8" />
    		<meta name="keywords" content="Abciximab,Abciximab.png,Antithrombotics,Chimericmonoclonals,Chimericmonoclonals,Antithrombotics,ATC code B01,Acenocoumarol,Acetylsalicylic acid,Anatomical Therapeutic Chemical Classification System,Ancrod" />
		<link rel="shortcut icon" href="/favicon.ico" />
		<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="Wikipedia (English)" />
		<link rel="copyright" href="../../../COPYING.html" />
    <title>Abciximab - Wikipedia, the free encyclopedia</title>
    <style type="text/css">/*<![CDATA[*/ @import "../../../skins/htmldump/main.css"; /*]]>*/</style>
    <link rel="stylesheet" type="text/css" media="print" href="../../../skins/common/commonPrint.css" />
    <!--[if lt IE 5.5000]><style type="text/css">@import "../../../skins/monobook/IE50Fixes.css";</style><![endif]-->
    <!--[if IE 5.5000]><style type="text/css">@import "../../../skins/monobook/IE55Fixes.css";</style><![endif]-->
    <!--[if IE 6]><style type="text/css">@import "../../../skins/monobook/IE60Fixes.css";</style><![endif]-->
    <!--[if IE]><script type="text/javascript" src="../../../skins/common/IEFixes.js"></script>
    <meta http-equiv="imagetoolbar" content="no" /><![endif]-->
    <script type="text/javascript" src="../../../skins/common/wikibits.js"></script>
    <script type="text/javascript" src="../../../skins/htmldump/md5.js"></script>
    <script type="text/javascript" src="../../../skins/htmldump/utf8.js"></script>
    <script type="text/javascript" src="../../../skins/htmldump/lookup.js"></script>
    <script type="text/javascript" src="../../../raw/gen.js"></script>        <style type="text/css">/*<![CDATA[*/
@import "../../../raw/MediaWiki%7ECommon.css";
@import "../../../raw/MediaWiki%7EMonobook.css";
@import "../../../raw/gen.css";
/*]]>*/</style>          </head>
  <body
    class="ns-0">
    <div id="globalWrapper">
      <div id="column-content">
	<div id="content">
	  <a name="top" id="contentTop"></a>
	        <h1 class="firstHeading">Abciximab</h1>
	  <div id="bodyContent">
	    <h3 id="siteSub">From Wikipedia, the free encyclopedia</h3>
	    <div id="contentSub"></div>
	    	    <div class="usermessage">You have <a href="../../../1/2/7/User_talk%7E127.0.0.1.html" title="User talk:127.0.0.1">new messages</a> (<a href="../../../1/2/7/User_talk%7E127.0.0.1.html" title="User talk:127.0.0.1">last change</a>).</div>	    <!-- start content -->
	    <table id="drugInfoBox" style="float: right; clear: right; margin: 0 0 0.5em 1em; background: #ffffff;" class="toccolours" border="0" cellpadding="1" align="right" width="280">
<tr>
<td align="center" colspan="2">
<div style="font-size:medium; line-height:167%;">Abciximab</div>
</td>
</tr>
<tr>
<td colspan="2" bgcolor="#DDDDDD">
<center><b><a href="../../../m/o/n/Monoclonal_antibody.html#Applications" title="Monoclonal antibody">Therapeutic monoclonal antibody</a></b></center>
</td>
</tr>
<tr>
<td bgcolor="#DDEEFF" style="vertical-align: top;"><a href="../../../m/o/n/Monoclonal_antibody.html#Production" title="Monoclonal antibody">Source</a></td>
<td bgcolor="#EEEEEE">chimeric/human</td>
</tr>
<tr>
<td bgcolor="#DDEEFF" style="vertical-align: top;"><a href="../../../a/n/t/Antigen.html" title="Antigen">Target</a></td>
<td bgcolor="#EEEEEE">CD41 7E3</td>
</tr>
<tr>
<td colspan="2" bgcolor="#DDDDDD"><b>Identifiers</b></td>
</tr>
<tr>
<td bgcolor="#DDEEFF" width="90"><a href="../../../c/a/s/CAS_registry_number_4b20.html" title="CAS registry number">CAS number</a></td>
<td bgcolor="#EEEEEE"><span class="reflink plainlinksneverexpand"><a href="http://www.nlm.nih.gov/cgi/mesh/2006/MB_cgi?term=143653-53-6&amp;rn=1" class="external text" title="http://www.nlm.nih.gov/cgi/mesh/2006/MB_cgi?term=143653-53-6&amp;rn=1" rel="nofollow">143653-53-6</a></span></td>
</tr>
<tr>
<td bgcolor="#DDEEFF"><a href="../../../a/n/a/Anatomical_Therapeutic_Chemical_Classification_System_186e.html" title="Anatomical Therapeutic Chemical Classification System">ATC code</a></td>
<td bgcolor="#EEEEEE"><a href="../../../a/t/c/ATC_code_B01_f871.html" title="ATC code B01">B01</a><span class="reflink plainlinksneverexpand"><a href="http://www.whocc.no/atcddd/indexdatabase/index.php?query=B01AC13" class="external text" title="http://www.whocc.no/atcddd/indexdatabase/index.php?query=B01AC13" rel="nofollow">AC13</a></span></td>
</tr>
<tr>
<td bgcolor="#DDEEFF"><a href="../../../d/r/u/DrugBank_2050.html" title="DrugBank">DrugBank</a></td>
<td bgcolor="#EEEEEE"><span class="reflink plainlinksneverexpand"><a href="http://redpoll.pharmacy.ualberta.ca/drugbank/cgi-bin/getCard.cgi?CARD=BTD00041" class="external text" title="http://redpoll.pharmacy.ualberta.ca/drugbank/cgi-bin/getCard.cgi?CARD=BTD00041" rel="nofollow">BTD00041</a></span></td>
</tr>
<tr>
<td colspan="2" bgcolor="#DDDDDD"><b>Chemical data</b></td>
</tr>
<tr>
<td bgcolor="#DDEEFF"><a href="../../../c/h/e/Chemical_formula.html" title="Chemical formula">Formula</a></td>
<td bgcolor="#EEEEEE"><a href="../../../c/a/r/Carbon.html" title="Carbon"><span style="color: rgb(000,000,000); font-weight: bold;">C</span></a><sub>6462</sub><a href="../../../h/y/d/Hydrogen.html" title="Hydrogen"><span style="color: rgb(154,154,154); font-weight: bold;">H</span></a><sub>9964</sub><a href="../../../n/i/t/Nitrogen.html" title="Nitrogen"><span style="color: rgb(000,000,255); font-weight: bold;">N</span></a><sub>1690</sub><a href="../../../o/x/y/Oxygen.html" title="Oxygen"><span style="color: rgb(232,070,070); font-weight: bold;">O</span></a><sub>2049</sub><a href="../../../s/u/l/Sulfur.html" title="Sulfur"><span style="color: rgb(229,197,063); font-weight: bold;">S</span></a><sub>48</sub><sup>&#160;</sup></td>
</tr>
<tr>
<td bgcolor="#DDEEFF"><a href="../../../m/o/l/Molecular_mass.html" title="Molecular mass">Mol. mass</a></td>
<td bgcolor="#EEEEEE">145651.1 g/mol</td>
</tr>
<tr>
<td colspan="2" bgcolor="#DDDDDD"><b>Pharmacokinetic data</b></td>
</tr>
<tr>
<td bgcolor="#DDEEFF" style="vertical-align: top;"><a href="../../../b/i/o/Bioavailability.html" title="Bioavailability">Bioavailability</a></td>
<td bgcolor="#EEEEEE">&#160;?</td>
</tr>
<tr>
<td bgcolor="#DDEEFF" style="vertical-align: top;"><a href="../../../d/r/u/Drug_metabolism.html" title="Drug metabolism">Metabolism</a></td>
<td bgcolor="#EEEEEE">&#160;?</td>
</tr>
<tr>
<td bgcolor="#DDEEFF" style="vertical-align: top;"><a href="../../../b/i/o/Biological_half-life.html" title="Biological half-life">Half life</a></td>
<td bgcolor="#EEEEEE">&lt;10 min-30 min</td>
</tr>
<tr>
<td bgcolor="#DDEEFF" style="vertical-align: top;"><a href="../../../e/x/c/Excretion.html" title="Excretion">Excretion</a></td>
<td bgcolor="#EEEEEE">&#160;?</td>
</tr>
<tr>
<td colspan="2" bgcolor="#DDDDDD"><b>Therapeutic considerations</b></td>
</tr>
<tr>
<td bgcolor="#DDEEFF" style="vertical-align: top;"><a href="../../../p/r/e/Pregnancy_category.html" title="Pregnancy category">Pregnancy cat.</a></td>
<td bgcolor="#EEEEEE">
<p>C <small>(US)</small></p>
</td>
</tr>
<tr>
<td bgcolor="#DDEEFF" style="vertical-align: top;"><a href="../../../r/e/g/Regulation_of_therapeutic_goods.html" title="Regulation of therapeutic goods">Legal status</a></td>
<td bgcolor="#EEEEEE"></td>
</tr>
<tr>
<td bgcolor="#DDEEFF" style="vertical-align: top;"><a href="../../../r/o/u/Route_of_administration.html" title="Route of administration">Routes</a></td>
<td bgcolor="#EEEEEE"><a href="../../../i/n/t/Intravenous.html" title="Intravenous">IV</a></td>
</tr>
</table>
<p><b>Abciximab</b> (previously known as <b>c7E3 Fab</b>), manufactured by <a href="../../../c/e/n/Centocor.html" title="Centocor">Centocor</a> and distributed by <a href="../../../e/l/i/Eli_Lilly_and_Company_7fa7.html" title="Eli Lilly and Company">Eli Lilly</a> under the trade name <b>ReoPro</b><sup>Â®</sup>, is a platelet aggregation inhibitor mainly used during and after <a href="../../../c/o/r/Coronary_artery.html" title="Coronary artery">coronary artery</a> procedures like <a href="../../../a/n/g/Angioplasty.html" title="Angioplasty">angioplasty</a> to prevent <a href="../../../p/l/a/Platelet.html" title="Platelet">platelets</a> from sticking together and causing thrombus (<a href="../../../b/l/o/Blood_clot.html" title="Blood clot">blood clot</a>) formation within the coronary artery. Its mechanism of action is inhibition of glycoprotein IIb/IIIa.</p>
<p>While Abciximab has a short plasma half life, due to its strong affinity for its receptor on the <a href="../../../p/l/a/Platelet.html" title="Platelet">platelets</a>, it may occupy some receptors for weeks. In practice, platelet aggregation gradually returns to normal about 24 to 48 hours after discontinuation of the drug.</p>
<p>Abciximab is made from the Fab fragments of an <a href="../../../i/m/m/Immunoglobulin.html" title="Immunoglobulin">immunoglobulin</a> that targets the glycoprotein IIb/IIIa receptor on the platelet membrane.</p>
<table id="toc" class="toc" summary="Contents">
<tr>
<td>
<div id="toctitle">
<h2>Contents</h2>
</div>
<ul>
<li class="toclevel-1"><a href="#Indications_for_use"><span class="tocnumber">1</span> <span class="toctext">Indications for use</span></a></li>
<li class="toclevel-1"><a href="#Pharmacokinetics"><span class="tocnumber">2</span> <span class="toctext">Pharmacokinetics</span></a></li>
<li class="toclevel-1"><a href="#Side_effects"><span class="tocnumber">3</span> <span class="toctext">Side effects</span></a></li>
<li class="toclevel-1"><a href="#References"><span class="tocnumber">4</span> <span class="toctext">References</span></a></li>
<li class="toclevel-1"><a href="#External_links"><span class="tocnumber">5</span> <span class="toctext">External links</span></a></li>
</ul>
</td>
</tr>
</table>
<p><script type="text/javascript">
//<![CDATA[
 if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } 
//]]>
</script><a name="Indications_for_use" id="Indications_for_use"></a></p>
<h2><span class="editsection">[<a href="../../../a/b/c/Abciximab.html" title="Edit section: Indications for use">edit</a>]</span> <span class="mw-headline">Indications for use</span></h2>
<p>Abciximab is indicated for use in individuals undergoing percutaneous coronary intervention (angioplasty with or without stent placement). The use of abciximab in this setting is associated with a decreased incidence of ischemic complications due to the procedure<sup id="_ref-0" class="reference"><a href="#_note-0" title="">[1]</a></sup> and a decreased need for repeated coronary artery revascularization in the first month following the procedure.<sup id="_ref-1" class="reference"><a href="#_note-1" title="">[2]</a></sup></p>
<p><a name="Pharmacokinetics" id="Pharmacokinetics"></a></p>
<h2><span class="editsection">[<a href="../../../a/b/c/Abciximab.html" title="Edit section: Pharmacokinetics">edit</a>]</span> <span class="mw-headline">Pharmacokinetics</span></h2>
<p>Abciximab has a plasma <a href="../../../h/a/l/Half_life.html" title="Half life">half life</a> of about ten minutes, with a second phase half life of about 30 minutes. However, its effects on platelet function can be seen for up to 48 hours after the infusion has been terminated, and low levels of glycoprotein IIb/IIIa receptor blockade are present for up to 15 days after the infusion is terminated.</p>
<p><a name="Side_effects" id="Side_effects"></a></p>
<h2><span class="editsection">[<a href="../../../a/b/c/Abciximab.html" title="Edit section: Side effects">edit</a>]</span> <span class="mw-headline">Side effects</span></h2>
<p>Many of the side effects of abciximab are due to its anti-platelet effects. This includes an increased risk of bleeding. The most common type of bleeding due to abciximab is gastrointestinal <a href="../../../h/e/m/Hemorrhage.html" title="Hemorrhage">hemorrhage</a>.</p>
<p><a href="../../../t/h/r/Thrombocytopenia.html" title="Thrombocytopenia">Thrombocytopenia</a> is a rare but known serious risk. Abciximab-induced thrombocytopenia can typically be treated with transfusion of <a href="../../../p/l/a/Platelet.html" title="Platelet">platelets</a>. Abciximab induced thrombocytopenia can last for five days after initial drug administration. Transfusing platelets is the only known treatment and may have limited effectiveness as the drug may also bind to the new platelets. Platelet counts which should average 250,000-400,000 can effectively drop to zero<sup class="noprint"><a href="../../../c/i/t/Wikipedia%7ECiting_sources_8ba4.html" title="Wikipedia:Citing sources"><span title="This claim needs references to reliable sources since March 2007" style="white-space: nowrap;">[<i>citation needed</i>]</span></a></sup>. This is not a particularly safe drug<sup class="noprint"><a href="../../../c/i/t/Wikipedia%7ECiting_sources_8ba4.html" title="Wikipedia:Citing sources"><span title="This claim needs references to reliable sources since March 2007" style="white-space: nowrap;">[<i>citation needed</i>]</span></a></sup> and this rare but dangerous side effect is not as easily reversed as one would like.</p>
<p><a name="References" id="References"></a></p>
<h2><span class="editsection">[<a href="../../../a/b/c/Abciximab.html" title="Edit section: References">edit</a>]</span> <span class="mw-headline">References</span></h2>
<ol class="references">
<li id="_note-0"><b><a href="#_ref-0" title="">^</a></b> Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. The EPIC Investigation. N Engl J Med. 1994 Apr 7;330(14):956-61. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=8121459" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=8121459">PMID 8121459</a>.</li>
<li id="_note-1"><b><a href="#_ref-1" title="">^</a></b> Tcheng JE, Kandzari DE, Grines CL, Cox DA, Effron MB, Garcia E, Griffin JJ, Guagliumi G, Stuckey T, Turco M, Fahy M, Lansky AJ, Mehran R, Stone GW; CADILLAC Investigators. Benefits and risks of abciximab use in primary angioplasty for acute myocardial infarction: the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial. Circulation. 2003 Sep 16;108(11):1316-23. Epub 2003 Aug 25. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=12939213" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=12939213">PMID 12939213</a>.</li>
</ol>
<p><a name="External_links" id="External_links"></a></p>
<h2><span class="editsection">[<a href="../../../a/b/c/Abciximab.html" title="Edit section: External links">edit</a>]</span> <span class="mw-headline">External links</span></h2>
<ul>
<li><a href="http://www.abciximab.com" class="external text" title="http://www.abciximab.com" rel="nofollow">Official website</a></li>
</ul>
<table class="navbox collapsible" style="margin: auto;">
<tr>
<th colspan="2" style="text-align:center;">
<div class="noprint plainlinksneverexpand" style="background-color:transparent; padding:0; font-weight:normal; font-size:xx-small; color:#000000; white-space:nowrap; float:left;width:6em;text-align:left;"><a href="../../../a/n/t/Template%7EAntithrombotics_5ce0.html" title="Template:Antithrombotics"><span title="View this template">v</span></a>&#160;<span style="font-size:80%;">â¢</span>&#160;<span style="color: #002bb8;" title="Discussion about this template">d</span>&#160;<span style="font-size:80%;">â¢</span>&#160;<a href="http://en.wikipedia.org../../../a/n/t/Template%7EAntithrombotics_5ce0.html" class="external text" title="http://en.wikipedia.org../../../a/n/t/Template%7EAntithrombotics_5ce0.html" rel="nofollow"><span style="color: #002bb8;" title="You can edit this template. Please use the preview button before saving.">e</span></a></div>
Antithrombotics (<a href="../../../t/h/r/Thrombolytic_drug.html" title="Thrombolytic drug">thrombolytics</a>, <a href="../../../a/n/t/Anticoagulant.html" title="Anticoagulant">anticoagulants</a>, and <a href="../../../a/n/t/Antiplatelet_drug.html" title="Antiplatelet drug">antiplatelet drugs</a>) (<a href="../../../a/t/c/ATC_code_B01_f871.html" title="ATC code B01">B01</a>)</th>
</tr>
<tr>
<th style=""><a href="../../../v/i/t/Vitamin_K_6c81.html" title="Vitamin K">Vitamin K</a> antagonists</th>
<td><a href="../../../a/c/e/Acenocoumarol.html" title="Acenocoumarol">Acenocoumarol</a>, Clorindione, <a href="../../../d/i/c/Dicumarol.html" title="Dicumarol">Dicumarol</a> (Dicoumarol), Diphenadione, Ethyl biscoumacetate, <a href="../../../p/h/e/Phenprocoumon.html" title="Phenprocoumon">Phenprocoumon</a>, <a href="../../../p/h/e/Phenindione.html" title="Phenindione">Phenindione</a>, Tioclomarol, <a href="../../../w/a/r/Warfarin.html" title="Warfarin">Warfarin</a></td>
</tr>
<tr>
<th style="">Heparin group<br />
(Platelet aggregation inhibitors)</th>
<td><a href="../../../a/n/t/Antithrombin_III_9434.html" title="Antithrombin III">Antithrombin III</a>, Bemiparin, <a href="../../../d/a/l/Dalteparin.html" title="Dalteparin">Dalteparin</a>, <a href="../../../d/a/n/Danaparoid.html" title="Danaparoid">Danaparoid</a>, <a href="../../../e/n/o/Enoxaparin.html" title="Enoxaparin">Enoxaparin</a>, <a href="../../../h/e/p/Heparin.html" title="Heparin">Heparin</a>, <a href="../../../n/a/d/Nadroparin.html" title="Nadroparin">Nadroparin</a>, Parnaparin, Reviparin, Sulodexide, Tinzaparin</td>
</tr>
<tr>
<th style="">Other&#160;platelet<br />
aggregation&#160;inhibitors</th>
<td><strong class="selflink">Abciximab</strong>, <a href="../../../a/c/e/Acetylsalicylic_acid.html" title="Acetylsalicylic acid">Acetylsalicylic acid</a> (Aspirin), Aloxiprin, <a href="../../../b/e/r/Beraprost.html" title="Beraprost">Beraprost</a>, Ditazole, Carbasalate calcium, Cloricromen, <a href="../../../c/l/o/Clopidogrel.html" title="Clopidogrel">Clopidogrel</a>, <a href="../../../d/i/p/Dipyridamole.html" title="Dipyridamole">Dipyridamole</a>,<a href="../../../e/p/t/Eptifibatide.html" title="Eptifibatide">Eptifibatide</a>, Indobufen, <a href="../../../i/l/o/Iloprost.html" title="Iloprost">Iloprost</a>, Picotamide, <a href="../../../p/r/a/Prasugrel.html" title="Prasugrel">Prasugrel</a>,<a href="../../../p/r/o/Prostacyclin.html" title="Prostacyclin">Prostacyclin</a>, <a href="../../../t/i/c/Ticlopidine.html" title="Ticlopidine">Ticlopidine</a>, <a href="../../../t/i/r/Tirofiban.html" title="Tirofiban">Tirofiban</a>, <a href="../../../t/r/e/Treprostinil.html" title="Treprostinil">Treprostinil</a>, Triflusal</td>
</tr>
<tr>
<th style="">Enzymes</th>
<td><a href="../../../t/i/s/Tissue_plasminogen_activator.html" title="Tissue plasminogen activator">Alteplase</a>, <a href="../../../a/n/c/Ancrod.html" title="Ancrod">Ancrod</a>, <a href="../../../a/n/i/Anistreplase.html" title="Anistreplase">Anistreplase</a>, Brinase, <a href="../../../d/r/o/Drotrecogin_alfa.html" title="Drotrecogin alfa">Drotrecogin alfa</a>, <a href="../../../f/i/b/Fibrinolysin.html" title="Fibrinolysin">Fibrinolysin</a>, <a href="../../../p/r/o/Protein_C_1c3a.html" title="Protein C">Protein C</a>, <a href="../../../r/e/t/Reteplase.html" title="Reteplase">Reteplase</a>, Saruplase, <a href="../../../s/t/r/Streptokinase.html" title="Streptokinase">Streptokinase</a>, <a href="../../../t/e/n/Tenecteplase.html" title="Tenecteplase">Tenecteplase</a>, <a href="../../../u/r/o/Urokinase.html" title="Urokinase">Urokinase</a></td>
</tr>
<tr>
<th style=""><a href="../../../d/i/r/Direct_thrombin_inhibitor.html" title="Direct thrombin inhibitor">Direct thrombin inhibitors</a></th>
<td><a href="../../../a/r/g/Argatroban.html" title="Argatroban">Argatroban</a>, <a href="../../../b/i/v/Bivalirudin.html" title="Bivalirudin">Bivalirudin</a>,<a href="../../../d/a/b/Dabigatran.html" title="Dabigatran">Dabigatran</a>, Desirudin, <a href="../../../h/i/r/Hirudin.html" title="Hirudin">Hirudin</a>, <a href="../../../l/e/p/Lepirudin.html" title="Lepirudin">Lepirudin</a>, <a href="../../../m/e/l/Melagatran.html" title="Melagatran">Melagatran</a>, <a href="../../../x/i/m/Ximelagatran.html" title="Ximelagatran">Ximelagatran</a></td>
</tr>
<tr>
<th style="">Other antithrombotics</th>
<td><a href="../../../d/e/f/Defibrotide.html" title="Defibrotide">Defibrotide</a>, <a href="../../../d/e/r/Dermatan_sulfate.html" title="Dermatan sulfate">Dermatan sulfate</a>, <a href="../../../f/o/n/Fondaparinux.html" title="Fondaparinux">Fondaparinux</a>, <a href="../../../r/i/v/Rivaroxaban.html" title="Rivaroxaban">Rivaroxaban</a></td>
</tr>
<tr>
<th style=""><a href="../../../a/n/t/Anticoagulant.html#Anticoagulants_outside_the_body" title="Anticoagulant">Non-medicinal</a></th>
<td><a href="../../../c/i/t/Citrate.html" title="Citrate">Citrate</a>, <a href="../../../e/d/t/EDTA_bb3f.html" title="EDTA">EDTA</a>, <a href="../../../o/x/a/Oxalate.html" title="Oxalate">Oxalate</a></td>
</tr>
</table>
<div class="NavFrame" style="clear:both;">
<div class="NavHead" style="background:#ccccff;">
<div class="noprint plainlinksneverexpand" style="background-color:transparent; padding:0; font-weight:normal; font-size:xx-small; color:#000000; white-space:nowrap; position:absolute; width:auto; left:0.5em;"><a href="../../../c/h/i/Template%7EChimericmonoclonals_ad1e.html" title="Template:Chimericmonoclonals"><span title="View this template">v</span></a>&#160;<span style="font-size:80%;">â¢</span>&#160;<a href="../../../c/h/i/Template_talk%7EChimericmonoclonals_608d.html" title="Template talk:Chimericmonoclonals"><span title="Discussion about this template">d</span></a>&#160;<span style="font-size:80%;">â¢</span>&#160;<a href="http://en.wikipedia.org../../../c/h/i/Template%7EChimericmonoclonals_ad1e.html" class="external text" title="http://en.wikipedia.org../../../c/h/i/Template%7EChimericmonoclonals_ad1e.html" rel="nofollow"><span style="color: #002bb8;" title="You can edit this template. Please use the preview button before saving.">e</span></a></div>
<b><a href="../../../c/h/i/Chimera_%28protein%29.html" title="Chimera (protein)">Chimeric</a> <a href="../../../m/o/n/Monoclonal_antibodies.html" title="Monoclonal antibodies">monoclonal antibodies</a></b></div>
<div class="NavContent" style="margin:0.5em; font-size:0.9em;">
<p><strong class="selflink">Abciximab</strong>, <a href="../../../b/a/s/Basiliximab.html" title="Basiliximab">Basiliximab</a>, <a href="../../../b/a/v/Bavituximab.html" title="Bavituximab">Bavituximab</a>, <a href="../../../c/e/t/Cetuximab.html" title="Cetuximab">Cetuximab</a>, <a href="../../../c/l/e/Clenoliximab.html" title="Clenoliximab">Clenoliximab</a>, <a href="../../../e/c/r/Ecromeximab.html" title="Ecromeximab">Ecromeximab</a>, <a href="../../../g/a/l/Galiximab.html" title="Galiximab">Galiximab</a>, <a href="../../../g/o/m/Gomiliximab.html" title="Gomiliximab">Gomiliximab</a>, <a href="../../../i/n/f/Infliximab.html" title="Infliximab">Infliximab</a>, <a href="../../../k/e/l/Keliximab.html" title="Keliximab">Keliximab</a>, <a href="../../../l/u/m/Lumiliximab.html" title="Lumiliximab">Lumiliximab</a>, <a href="../../../p/a/g/Pagibaximab.html" title="Pagibaximab">Pagibaximab</a>, <a href="../../../r/i/t/Rituximab.html" title="Rituximab">Rituximab</a>, <a href="../../../t/e/n/Teneliximab.html" title="Teneliximab">Teneliximab</a>, <a href="../../../v/a/p/Vapaliximab.html" title="Vapaliximab">Vapaliximab</a>, <a href="../../../v/o/l/Volociximab.html" title="Volociximab">Volociximab</a></p>
</div>
</div>

<!-- 
Pre-expand include size: 42893 bytes
Post-expand include size: 21386 bytes
Template argument size: 6886 bytes
Maximum: 2048000 bytes
-->
<div class="printfooter">
Retrieved from "<a href="http://en.wikipedia.org../../../a/b/c/Abciximab.html">http://en.wikipedia.org../../../a/b/c/Abciximab.html</a>"</div>
	    <div id="catlinks"><p class='catlinks'><a href="../../../c/a/t/Special%7ECategories_101d.html" title="Special:Categories">Categories</a>: <span dir='ltr'><a href="../../../m/o/n/Category%7EMonoclonal_antibody_pages_needing_a_picture_58d4.html" title="Category:Monoclonal antibody pages needing a picture">Monoclonal antibody pages needing a picture</a></span> | <span dir='ltr'><a href="../../../a/r/t/Category%7EArticles_with_unsourced_statements_since_March_2007_2536.html" title="Category:Articles with unsourced statements since March 2007">Articles with unsourced statements since March 2007</a></span> | <span dir='ltr'><a href="../../../a/l/l/Category%7EAll_articles_with_unsourced_statements_2f67.html" title="Category:All articles with unsourced statements">All articles with unsourced statements</a></span> | <span dir='ltr'><a href="../../../g/p/i/Category%7EGpIIb_IIIa_inhibitors_3256.html" title="Category:GpIIb/IIIa inhibitors">GpIIb/IIIa inhibitors</a></span> | <span dir='ltr'><a href="../../../m/o/n/Category%7EMonoclonal_antibodies_272e.html" title="Category:Monoclonal antibodies">Monoclonal antibodies</a></span> | <span dir='ltr'><a href="../../../c/e/n/Category%7ECentocor_6d1c.html" title="Category:Centocor">Centocor</a></span></p></div>	    <!-- end content -->
	    <div class="visualClear"></div>
	  </div>
	</div>
      </div>
      <div id="column-one">
	<div id="p-cactions" class="portlet">
	  <h5>Views</h5>
	  <ul>
	    <li id="ca-nstab-main"
	       class="selected"	       ><a href="../../../a/b/c/Abciximab.html">Article</a></li><li id="ca-talk"
	       class="new"	       ><a href="../../../a/b/c/Talk%7EAbciximab_3263.html">Discussion</a></li><li id="ca-current"
	       	       ><a href="http://en.wikipedia.org/wiki/Abciximab">Current revision</a></li>	  </ul>
	</div>
	<div class="portlet" id="p-logo">
	  <a style="background-image: url(../../../images/wiki-en.png);"
	    href="../../../index.html"
	    title="Main Page"></a>
	</div>
	<script type="text/javascript"> if (window.isMSIE55) fixalpha(); </script>
		<div class='portlet' id='p-navigation'>
	  <h5>Navigation</h5>
	  <div class='pBody'>
	    <ul>
	    	      <li id="n-Main-page"><a href="../../../index.html">Main page</a></li>
	     	      <li id="n-Contents"><a href="../../../c/o/n/Wikipedia%7EContents_3181.html">Contents</a></li>
	     	      <li id="n-Featured-content"><a href="../../../f/e/a/Wikipedia%7EFeatured_content_24ba.html">Featured content</a></li>
	     	      <li id="n-currentevents"><a href="../../../c/u/r/Portal%7ECurrent_events_bb60.html">Current events</a></li>
	     	    </ul>
	  </div>
	</div>
		<div class='portlet' id='p-interaction'>
	  <h5>interaction</h5>
	  <div class='pBody'>
	    <ul>
	    	      <li id="n-About-Wikipedia"><a href="../../../a/b/o/Wikipedia%7EAbout_8d82.html">About Wikipedia</a></li>
	     	      <li id="n-portal"><a href="../../../c/o/m/Wikipedia%7ECommunity_Portal_6a3c.html">Community portal</a></li>
	     	      <li id="n-contact"><a href="../../../c/o/n/Wikipedia%7EContact_us_afd6.html">Contact us</a></li>
	     	      <li id="n-sitesupport"><a href="http://wikimediafoundation.org/wiki/Fundraising">Make a donation</a></li>
	     	      <li id="n-help"><a href="../../../c/o/n/Help%7EContents_22de.html">Help</a></li>
	     	    </ul>
	  </div>
	</div>
		<div id="p-search" class="portlet">
	  <h5><label for="searchInput">Search</label></h5>
	  <div id="searchBody" class="pBody">
	    <form action="javascript:goToStatic(3)" id="searchform"><div>
	      <input id="searchInput" name="search" type="text"
	        accesskey="f" value="" />
	      <input type='submit' name="go" class="searchButton" id="searchGoButton"
	        value="Go" />
	    </div></form>
	  </div>
	</div>
	<div id="p-lang" class="portlet">
	  <h5>In other languages</h5>
	  <div class="pBody">
	    <ul>
	      	      <li>
	      <a href="../../../../pt/a/b/c/Abciximab.html">PortuguÃªs</a>
	      </li>
	      	    </ul>
	  </div>
	</div>
	      </div><!-- end of the left (by default at least) column -->
      <div class="visualClear"></div>
      <div id="footer">
    <div id="f-poweredbyico"><a href="http://www.mediawiki.org/"><img src="../../../skins/common/images/poweredby_mediawiki_88x31.png" alt="Powered by MediaWiki" /></a></div>	<div id="f-copyrightico"><a href="http://wikimediafoundation.org/"><img src="../../../images/wikimedia-button.png" border="0" alt="Wikimedia Foundation"/></a></div>	<ul id="f-list">
	  	  	  <li id="f-credits">This page was last modified 01:22, 20 March 2007 by Wikipedia user <a href="../../../s/m/a/User%7ESmackBot_cc7a.html" title="User:SmackBot">SmackBot</a>. Based on work by Wikipedia user(s) <a href="../../../e/r/i/User%7EErich_gasboy_b37c.html" title="User:Erich gasboy">Erich gasboy</a>, <a href="../../../b/l/a/User%7EBlakeCS_39b1.html" title="User:BlakeCS">BlakeCS</a>, <a href="../../../s/e/l/User%7ESelket_adc6.html" title="User:Selket">Selket</a>, <a href="../../../d/v/d/User%7EDVD_R_W_e2d2.html" title="User:DVD R W">DVD R W</a>, <a href="../../../h/o/n/User%7EHonoluluGuy_6cbe.html" title="User:HonoluluGuy">HonoluluGuy</a>, <a href="../../../k/s/h/User%7EKsheka_e2cf.html" title="User:Ksheka">Ksheka</a>, <a href="../../../b/l/u/User%7EBluebot_e595.html" title="User:Bluebot">Bluebot</a>, <a href="../../../a/p/p/User%7EApparent_Logic_937b.html" title="User:Apparent Logic">Apparent Logic</a>, Noahvale, <a href="../../../a/r/c/User%7EArcadian_5c4b.html" title="User:Arcadian">Arcadian</a>, <a href="../../../n/e/p/User%7ENephron_555e.html" title="User:Nephron">Nephron</a>, <a href="../../../j/f/d/User%7EJfdwolff_9ea6.html" title="User:Jfdwolff">Jfdwolff</a>, <a href="../../../s/t/e/User%7ESteinsky_9c79.html" title="User:Steinsky">Steinsky</a>, <a href="../../../a/x/l/User%7EAxl_2118.html" title="User:Axl">Axl</a>, <a href="../../../s/a/m/User%7ESam_Hocevar_dccf.html" title="User:Sam Hocevar">Sam Hocevar</a> and <a href="../../../w/i/l/User%7EWilliamb_4927.html" title="User:Williamb">Williamb</a> and Anonymous user(s) of Wikipedia.</li>	  <li id="f-copyright">All text is available under the terms of the <a class='internal' href="../../../t/e/x/Wikipedia%7EText_of_the_GNU_Free_Documentation_License_702a.html" title="Wikipedia:Text of the GNU Free Documentation License">GNU Free Documentation License</a>. (See <b><a class='internal' href="../../../c/o/p/Wikipedia%7ECopyrights_92c4.html" title="Wikipedia:Copyrights">Copyrights</a></b> for details.) <br /> Wikipedia&reg; is a registered trademark of the <a href="http://www.wikimediafoundation.org">Wikimedia Foundation, Inc</a>., a US-registered <a class='internal' href="../../../5/0/1/501%28c%29.html#501.28c.29.283.29" title="501(c)(3)">501(c)(3)</a> <a href="http://wikimediafoundation.org/wiki/Deductibility_of_donations">tax-deductible</a> <a class='internal' href="../../../n/o/n/Non-profit_organization.html" title="Non-profit organization">nonprofit</a> <a href="../../../c/h/a/Charitable_organization.html" title="Charitable organization">charity</a>.<br /></li>	  <li id="f-about"><a href="../../../a/b/o/Wikipedia%7EAbout_8d82.html" title="Wikipedia:About">About Wikipedia</a></li>	  <li id="f-disclaimer"><a href="../../../g/e/n/Wikipedia%7EGeneral_disclaimer_3e44.html" title="Wikipedia:General disclaimer">Disclaimers</a></li>	  	</ul>
      </div>
    </div>
  </body>
</html>
